SEARCH

SEARCH BY CITATION

Cited in:

CrossRef

This article has been cited by:

  1. 1
    Yasuhiro Ishihara, Kouichi Itoh, Atsuhiko Ishida, Takeshi Yamazaki, Selective estrogen-receptor modulators suppress microglial activation and neuronal cell death via an estrogen receptor-dependent pathway, The Journal of Steroid Biochemistry and Molecular Biology, 2015, 145, 85

    CrossRef

  2. 2
    Augusta Pisanu, Daniela Lecca, Giovanna Mulas, Jadwiga Wardas, Gabriella Simbula, Saturnino Spiga, Anna R. Carta, Dynamic changes in pro- and anti-inflammatory cytokines in microglia after PPAR-γ agonist neuroprotective treatment in the MPTPp mouse model of progressive Parkinson's disease, Neurobiology of Disease, 2014, 71, 280

    CrossRef

  3. 3
    Erika Elgstrand Wettergren, Luis Quintino, Cecilia Lundberg, Gene therapy using synthetic microRNA directed against GAD67 has beneficial effect on motor behaviour in 6-OHDA lesioned rats, Journal of Gene Therapy Aspects, 2014, 1, 1, 1

    CrossRef

  4. 4
    Jürgen Berg, Manfred Roch, Jennifer Altschüler, Christine Winter, Anne Schwerk, Andreas Kurtz, Barbara Steiner, Human adipose-Derived Mesenchymal Stem Cells Improve Motor Functions and are Neuroprotective in the 6-Hydroxydopamine-Rat Model for Parkinson’s Disease when Cultured in Monolayer Cultures but Suppress Hippocampal Neurogenesis and Hippocampal Memory Function when Cultured in Spheroids, Stem Cell Reviews and Reports, 2014,

    CrossRef

  5. 5
    Zi-ang Yao, Ling Xu, Hai-ge Wu, Immunomodulatory Function of κ-Carrageenan Oligosaccharides Acting on LPS-Activated Microglial Cells, Neurochemical Research, 2014, 39, 2, 333

    CrossRef

  6. 6
    Guy C. Brown, Jonas J. Neher, Microglial phagocytosis of live neurons, Nature Reviews Neuroscience, 2014, 15, 4, 209

    CrossRef

  7. 7
    Claire J. Williams, David T. Dexter, Neuroprotective and symptomatic effects of targeting group III mGlu receptors in neurodegenerative disease, Journal of Neurochemistry, 2014, 129, 1
  8. 8
    Andrew L. Eagle, Oluyemi O. Olumolade, Hajime Otani, Partial dopaminergic denervation-induced impairment in stimulus discrimination acquisition in parkinsonian rats: A model for early Parkinson's disease, Neuroscience Research, 2014,

    CrossRef

  9. 9
    Ruying Fu, Qingyu Shen, Pengfei Xu, Jin Jun Luo, Yamei Tang, Phagocytosis of Microglia in the Central Nervous System Diseases, Molecular Neurobiology, 2014, 49, 3, 1422

    CrossRef

  10. 10
    Ana M. Espinosa-Oliva, Rocío M. de Pablos, Manuel Sarmiento, Ruth F. Villarán, Alejandro Carrillo-Jiménez, Marti Santiago, José L. Venero, Antonio J. Herrera, Josefina Cano, Alberto Machado, Role of dopamine in the recruitment of immune cells to the nigro-striatal dopaminergic structures, NeuroToxicology, 2014, 41, 89

    CrossRef

  11. 11
    J. Schapansky, J.D. Nardozzi, M.J. LaVoie, The complex relationships between microglia, alpha-synuclein, and LRRK2 in Parkinson’s disease, Neuroscience, 2014,

    CrossRef

  12. 12
    Fei-Long Zhang, Yi He, Yan Zheng, Wen-Jing Zhang, Qi Wang, Yan-Jun Jia, Hai-Long Song, Hai-Ting An, Hao-Bo Zhang, Yan-Jing Qian, Yu-Long Tong, Lin Dong, Xiao-Min Wang, Therapeutic Effects of Fucoidan in 6-Hydroxydopamine-Lesioned Rat Model of Parkinson's disease: Role of NADPH oxidase-1, CNS Neuroscience & Therapeutics, 2014, 20, 12
  13. 13
    Simon R.W. Stott, Roger A. Barker, Time course of dopamine neuron loss and glial response in the 6-OHDA striatal mouse model of Parkinson's disease, European Journal of Neuroscience, 2014, 39, 6
  14. 14
    Ilse S. Pienaar, Ian F. Harrison, Joanna L. Elson, Alexander Bury, Petter Woll, Anna Katharina Simon, David T. Dexter, An animal model mimicking pedunculopontine nucleus cholinergic degeneration in Parkinson’s disease, Brain Structure and Function, 2013,

    CrossRef

  15. 15
    Suraj Pradhan, Katrin Andreasson, Commentary: Progressive inflammation as a contributing factor to early development of Parkinson's disease, Experimental Neurology, 2013, 241, 148

    CrossRef

  16. 16
    Angélique Virgone-Carlotta, Josselin Uhlrich, Muhammad Numan Akram, Denis Ressnikoff, Fabrice Chrétien, Chantal Domenget, Romain Gherardi, Geneviève Despars, Pierre Jurdic, Jérôme Honnorat, Serge Nataf, Monique Touret, Mapping and kinetics of microglia/neuron cell-to-cell contacts in the 6-OHDA murine model of Parkinson's disease, Glia, 2013, 61, 10
  17. 17
    Fabio Blandini, Neural and Immune Mechanisms in the Pathogenesis of Parkinson’s Disease, Journal of Neuroimmune Pharmacology, 2013, 8, 1, 189

    CrossRef

  18. 18
    Vanesa Sanchez-Guajardo, Christopher J. Barnum, Malú G. Tansey, Marina Romero-Ramos, Neuroimmunological processes in Parkinson's disease and their relation to α-synuclein: microglia as the referee between neuronal processes and peripheral immunity, ASN NEURO, 2013, 5, 2, 113

    CrossRef

  19. 19
    Hugh H.N. Chan, Saravana Kumar, Lang Zhuo, Neuroprotective and behavioural assessments of an imidazolium compound (DBZIM) in a rat model of Parkinson's disease induced by 6-OHDA, European Journal of Pharmacology, 2013, 715, 1-3, 405

    CrossRef

  20. 20
    Mei jiang Feng, Ling Zhang, Zhengxia Liu, Ping Zhou, Xiang Lu, The Expression and Release of Hsp60 in 6-OHDA Induced In Vivo and In Vitro Models of Parkinson’s Disease, Neurochemical Research, 2013, 38, 10, 2180

    CrossRef

  21. 21
    M. Sadeghian, L. Marinova-Mutafchieva, L. Broom, J.B. Davis, D. Virley, A.D. Medhurst, D.T. Dexter, Full and partial peroxisome proliferation-activated receptor-gamma agonists, but not delta agonist, rescue of dopaminergic neurons in the 6-OHDA Parkinsonian model is associated with inhibition of microglial activation and MMP expression, Journal of Neuroimmunology, 2012, 246, 1-2, 69

    CrossRef

  22. 22
    P. Barkholt, V. Sanchez-Guajardo, D. Kirik, M. Romero-Ramos, Long-term polarization of microglia upon α-synuclein overexpression in nonhuman primates, Neuroscience, 2012, 208, 85

    CrossRef

  23. 23
    Serge Maia, Nicolas Arlicot, Emilie Vierron, Sylvie Bodard, Jackie Vergote, Denis Guilloteau, Sylvie Chalon, Longitudinal and parallel monitoring of neuroinflammation and neurodegeneration in a 6-hydroxydopamine rat model of Parkinson's disease, Synapse, 2012, 66, 7
  24. 24
    J. Bové, C. Perier, Neurotoxin-based models of Parkinson's disease, Neuroscience, 2012, 211, 51

    CrossRef

  25. 25
    Xing-Mei Zhang, Xi-Jing Mao, Hong-Liang Zhang, Xiang-Yu Zheng, Therese Pham, Abdu Adem, Bengt Winblad, Eilhard Mix, Jie Zhu, Overexpression of apolipoprotein E4 increases kainic-acid-induced hippocampal neurodegeneration, Experimental Neurology, 2012, 233, 1, 323

    CrossRef

  26. 26
    Eun Young Lee, Jeong Eun Lee, Jae Hyeon Park, In Chul Shin, Hyun Chul Koh, Rosiglitazone, a PPAR-γ agonist, protects against striatal dopaminergic neurodegeneration induced by 6-OHDA lesions in the substantia nigra of rats, Toxicology Letters, 2012, 213, 3, 332

    CrossRef

  27. 27
    Ling Xu, Ziang Yao, Haige Wu, Feifei Wang, Shengxia Zhang, The immune regulation of κ-carrageenan oligosaccharide and its desulfated derivatives on LPS-activated microglial cells, Neurochemistry International, 2012, 61, 5, 689

    CrossRef

  28. 28
    Kemal Ugur Tufekci, Ralph Meuwissen, Sermin Genc, Kursad Genc, Advances in Protein Chemistry and Structural Biology Volume 88, 2012,

    CrossRef

  29. 29
    Mohammed Emamussalehin Choudhury, Kana Sugimoto, Madoka Kubo, Masahiro Nagai, Masahiro Nomoto, Hisaaki Takahashi, Hajime Yano, Junya Tanaka, A cytokine mixture of GM-CSF and IL-3 that induces a neuroprotective phenotype of microglia leading to amelioration of (6-OHDA)-induced Parkinsonism of rats, Brain and Behavior, 2011, 1, 1
  30. 30
    L. Macgillivray, K.B. Reynolds, M. Sickand, P.I. Rosebush, M.F. Mazurek, Inhibition of the serotonin transporter induces microglial activation and downregulation of dopaminergic neurons in the substantia nigra, Synapse, 2011, 65, 11
  31. 31
    Xiang-Yu Zheng, Hong-Liang Zhang, Qi Luo, Jie Zhu, Kainic Acid-Induced Neurodegenerative Model: Potentials and Limitations, Journal of Biomedicine and Biotechnology, 2011, 2011, 1

    CrossRef

  32. 32
    Lauren Broom, Lilia Marinova-Mutafchieva, Mona Sadeghian, John B. Davis, Andrew D. Medhurst, David T. Dexter, Neuroprotection by the selective iNOS inhibitor GW274150 in a model of Parkinson disease, Free Radical Biology and Medicine, 2011, 50, 5, 633

    CrossRef

  33. 33
    S. Walsh, D.P. Finn, E. Dowd, Time-course of nigrostriatal neurodegeneration and neuroinflammation in the 6-hydroxydopamine-induced axonal and terminal lesion models of Parkinson's disease in the rat, Neuroscience, 2011, 175, 251

    CrossRef

  34. 34
    G. Ambrosi, M.-T. Armentero, G. Levandis, P. Bramanti, G. Nappi, F. Blandini, Effects of early and delayed treatment with an mGluR5 antagonist on motor impairment, nigrostriatal damage and neuroinflammation in a rodent model of Parkinson's disease, Brain Research Bulletin, 2010, 82, 1-2, 29

    CrossRef

  35. 35
    Elisabetta Polazzi, Barbara Monti, Microglia and neuroprotection: From in vitro studies to therapeutic applications, Progress in Neurobiology, 2010, 92, 3, 293

    CrossRef

  36. 36
    Vija Z. Klusa, Sergejs Isajevs, Darja Svirina, Jolanta Pupure, Ulrika Beitnere, Juris Rumaks, Simons Svirskis, Baiba Jansone, Zane Dzirkale, Ruta Muceniece, Ivars Kalvinsh, Harry V. Vinters, Neuroprotective Properties of Mildronate, a Small Molecule, in a Rat Model of Parkinson’s Disease, International Journal of Molecular Sciences, 2010, 11, 11, 4465

    CrossRef

  37. 37
    Cui Long-Biao, Li Bo-Wei, Jin Xiao-Hang, Zhao Lin, Shi Juan, Progressive changes of orexin system in a rat model of 6-hydroxydopamineinduced Parkinson’s disease, Neuroscience Bulletin, 2010, 26, 5, 381

    CrossRef

  38. 38
    PJ Austin, MJ Betts, M Broadstock, MJ O'Neill, SN Mitchell, S Duty, Symptomatic and neuroprotective effects following activation of nigral group III metabotropic glutamate receptors in rodent models of Parkinson's disease, British Journal of Pharmacology, 2010, 160, 7
  39. 39
    Agata Adamczyk, Anna Kaźmierczak, Grzegorz Arkadiusz Czapski, Joanna Benigna Strosznajder, α-Synuclein induced cell death in mouse hippocampal (HT22) cells is mediated by nitric oxide-dependent activation of caspase-3, FEBS Letters, 2010, 584, 15, 3504

    CrossRef

  40. 40
    Magdalena Sastre, Loukia Katsouri, Amy Birch, Alexander Renziehausen, David T. Dexter, Robert R. Crichton, Roberta J. Ward, Neuroinflammation in Alzheimer's, Parkinson's and Huntington's Diseases,